Bioter S.A. (ATH:BIOT)
Greece · Delayed Price · Currency is EUR 0.2060
0.00 (0.00%)
May 29, 2025, 5:08 PM EET
Bioter Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1.26 | 1.26 | 0.5 | 0.25 | 0.25 | 0.23 | |
Revenue Growth (YoY) | 350.71% | 151.50% | 98.02% | 2.44% | 7.90% | -8.80% |
Cost of Revenue | 0.31 | 0.3 | 0.55 | 0.27 | 1.18 | 1.68 |
Gross Profit | 0.96 | 0.96 | -0.05 | -0.02 | -0.94 | -1.45 |
Selling, General & Admin | 14.37 | 12.95 | 2.43 | 1.42 | 0.51 | 0.7 |
Other Operating Expenses | -55.83 | - | - | - | - | - |
Operating Expenses | -41.46 | 12.95 | 2.43 | 1.42 | 0.51 | 0.7 |
Operating Income | 42.42 | -11.99 | -2.48 | -1.43 | -1.44 | -2.15 |
Interest Expense | -6.2 | -10.96 | -10.18 | -9.53 | -8.59 | -9.89 |
Interest & Investment Income | 0.05 | 0.04 | - | 0.01 | 0.35 | - |
Earnings From Equity Investments | 0.12 | 0.12 | - | - | 0.08 | -0.01 |
Other Non Operating Income (Expenses) | 0.03 | 0.03 | 0.02 | 0.03 | 0.38 | -0.03 |
EBT Excluding Unusual Items | 36.43 | -22.77 | -12.63 | -10.92 | -9.22 | -12.08 |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.69 | -0.05 |
Gain (Loss) on Sale of Assets | - | - | 0.35 | - | - | - |
Asset Writedown | 0.34 | 0.34 | 0.25 | 0.76 | 0.77 | 0.4 |
Legal Settlements | 0.15 | 0.15 | - | - | - | - |
Other Unusual Items | 0.15 | 0.13 | - | 0.71 | 0.33 | 18.66 |
Pretax Income | 37.06 | -22.15 | -12.03 | -9.45 | -8.8 | 6.93 |
Income Tax Expense | -1.24 | -1.02 | -0.26 | 0.21 | 0.02 | 1.02 |
Earnings From Continuing Operations | 38.3 | -21.13 | -11.78 | -9.66 | -8.82 | 5.92 |
Minority Interest in Earnings | -0.06 | -0.13 | 0.1 | -0.01 | 0.01 | 0.14 |
Net Income | 38.24 | -21.26 | -11.68 | -9.68 | -8.81 | 6.05 |
Net Income to Common | 38.24 | -21.26 | -11.68 | -9.68 | -8.81 | 6.05 |
Shares Outstanding (Basic) | 17 | 17 | 17 | 17 | 17 | 17 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 17 | 17 | 17 |
Shares Change (YoY) | - | - | - | - | - | 0.04% |
EPS (Basic) | 2.29 | -1.27 | -0.70 | -0.58 | -0.53 | 0.36 |
EPS (Diluted) | 2.29 | -1.27 | -0.70 | -0.58 | -0.53 | 0.36 |
Free Cash Flow | 48.78 | -12.05 | -5.79 | -9.46 | -6.43 | -9.1 |
Free Cash Flow Per Share | 2.92 | -0.72 | -0.35 | -0.56 | -0.38 | -0.54 |
Gross Margin | 75.67% | 76.33% | -9.62% | -5.95% | - | - |
Operating Margin | 3361.25% | -955.70% | -495.99% | -569.05% | -585.37% | -942.10% |
Profit Margin | 3030.43% | -1693.87% | -2340.88% | -3840.08% | -3580.89% | 2655.26% |
Free Cash Flow Margin | 3865.45% | -960.32% | -1160.92% | -3753.18% | -2612.19% | -3991.67% |
EBITDA | 42.49 | -11.9 | -2.38 | -1.34 | -1.32 | -2.04 |
EBITDA Margin | 3367.12% | - | - | - | - | - |
D&A For EBITDA | 0.07 | 0.09 | 0.09 | 0.09 | 0.12 | 0.11 |
EBIT | 42.42 | -11.99 | -2.48 | -1.43 | -1.44 | -2.15 |
EBIT Margin | 3361.25% | - | - | - | - | - |
Effective Tax Rate | - | - | - | - | - | 14.70% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.